Progyny Inc (PGNY) support and resistance · P/E 38, rev $298.4M
Progyny Inc (PGNY) is a healthcare plans company listed on US.
This page maps Progyny Inc (PGNY) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported PGNY revenue for 2024-12-31 was $298.4M. Net income was $54.3M. Revenue was up 4.1% from 2024-09-30 to 2024-12-31. PGNY currently screens at market cap $1.84B and trailing P/E 37.6.
PGNY currently screens at market cap $1.84B and trailing P/E 37.6. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new PGNY 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the PGNY quote page for the session range and the stock page for the full model.
Not investment advice.